ANO3 and chronic kidney disease: Understanding ANO3's involvement in CKD also opens therapeutic avenues: if ANO3-mediated chloride flux is indeed influencing disease progression, it could be targeted by drugs aimed at restoring electrolyte homeostasis, and patients carrying ANO3 risk alleles might benefit from precision medicine strategies tailored to their genetic profile [27].